{"id":236111,"date":"2026-09-09T10:11:50","date_gmt":"2026-09-09T04:41:50","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=236111"},"modified":"2026-09-09T10:11:50","modified_gmt":"2026-09-09T04:41:50","slug":"anlon-healthcare-q2-results-fy27-preview-date-expectations","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/","title":{"rendered":"Anlon Healthcare Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Anlon Healthcare share price Rs 16.05 on 9 September 2026, up 2.82%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 4.80 crore. Q2 FY26 base a profit of Rs 9.32 crore.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The Anlon Healthcare Q2 results date for FY27 is not confirmed, and Anlon Healthcare Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 52.20 crore in revenue and a profit of Rs 9.32 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.<\/p>\n<\/p><\/div>\n<p>The Anlon Healthcare Q2 results FY27 announcement is the next scheduled earnings event for <a href=\"https:\/\/univest.in\/stocks\/ahcl\/anlon-healthcare-limited-share-price-today\">Anlon Healthcare Ltd.<\/a>, a manufacturer of pharmaceutical excipients, active ingredients and speciality chemicals supplying formulation and nutraceutical customers. The stock traded at Rs 16.05 on the NSE on 9 September 2026, up 2.82% from the previous close of Rs 15.61, about 7.1% below its 52-week high of Rs 17.28 and 73.3% above its 52-week low of Rs 9.26.<\/p>\n<p>What makes the Anlon Healthcare Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 52.20 crore of revenue and a profit of Rs 9.32 crore, while the most recent quarter on record, Q1 FY27, produced Rs 30.98 crore and a profit of Rs 4.80 crore. Everything below is built from those reported figures rather than from any forecast.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=ahcl_q2_fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#When_Is_the_Anlon_Healthcare_Q2_Results_FY27_Date\" title=\"When Is the Anlon Healthcare Q2 Results FY27 Date?\">When Is the Anlon Healthcare Q2 Results FY27 Date?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#Anlon_Healthcare_Q2_Results_Expectations_What_the_Market_Is_Actually_Tracking\" title=\"Anlon Healthcare Q2 Results Expectations: What the Market Is Actually Tracking\">Anlon Healthcare Q2 Results Expectations: What the Market Is Actually Tracking<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#Anlon_Healthcare_Q2_Results_Preview_The_Q1_FY27_Actuals_It_Builds_On\" title=\"Anlon Healthcare Q2 Results Preview: The Q1 FY27 Actuals It Builds On\">Anlon Healthcare Q2 Results Preview: The Q1 FY27 Actuals It Builds On<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#Q2_FY26_Base_The_Comparison_Anlon_Healthcare_Q2_Results_FY27_Must_Beat\" title=\"Q2 FY26 Base: The Comparison Anlon Healthcare Q2 Results FY27 Must Beat\">Q2 FY26 Base: The Comparison Anlon Healthcare Q2 Results FY27 Must Beat<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#Anlon_Healthcare_Quarterly_Results_Trend_Over_the_Last_Four_Quarters\" title=\"Anlon Healthcare Quarterly Results Trend Over the Last Four Quarters\">Anlon Healthcare Quarterly Results Trend Over the Last Four Quarters<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#Key_Factors_That_Could_Shape_Anlon_Healthcare_Q2_Results_FY27\" title=\"Key Factors That Could Shape Anlon Healthcare Q2 Results FY27\">Key Factors That Could Shape Anlon Healthcare Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#Campaign-Based_Order_Flow\" title=\"Campaign-Based Order Flow\">Campaign-Based Order Flow<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#Customer_Concentration_and_Approvals\" title=\"Customer Concentration and Approvals\">Customer Concentration and Approvals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#Recent_Listing_and_a_Strong_Run\" title=\"Recent Listing and a Strong Run\">Recent Listing and a Strong Run<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#Anlon_Healthcare_Q2_Results_FY27_Share_Price_and_Valuation_Going_Into_the_Print\" title=\"Anlon Healthcare Q2 Results FY27: Share Price and Valuation Going Into the Print\">Anlon Healthcare Q2 Results FY27: Share Price and Valuation Going Into the Print<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#What_Investors_Should_Watch_When_Anlon_Healthcare_Q2_Results_Are_Announced\" title=\"What Investors Should Watch When Anlon Healthcare Q2 Results Are Announced\">What Investors Should Watch When Anlon Healthcare Q2 Results Are Announced<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#Conclusion_on_Anlon_Healthcare_Q2_Results_FY27\" title=\"Conclusion on Anlon Healthcare Q2 Results FY27\">Conclusion on Anlon Healthcare Q2 Results FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#FAQs_on_Anlon_Healthcare_Q2_Results_FY27\" title=\"FAQs on Anlon Healthcare Q2 Results FY27\">FAQs on Anlon Healthcare Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#What_is_the_Anlon_Healthcare_Q2_results_date_for_FY27\" title=\"What is the Anlon Healthcare Q2 results date for FY27?\">What is the Anlon Healthcare Q2 results date for FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#What_quarter_do_the_Anlon_Healthcare_Q2_results_2026_cover\" title=\"What quarter do the Anlon Healthcare Q2 results 2026 cover?\">What quarter do the Anlon Healthcare Q2 results 2026 cover?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#What_were_the_Anlon_Healthcare_Q1_FY27_results\" title=\"What were the Anlon Healthcare Q1 FY27 results?\">What were the Anlon Healthcare Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#What_were_Anlon_Healthcare_Q2_FY26_results_in_the_September_2025_quarter\" title=\"What were Anlon Healthcare Q2 FY26 results in the September 2025 quarter?\">What were Anlon Healthcare Q2 FY26 results in the September 2025 quarter?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#What_are_the_main_Anlon_Healthcare_Q2_results_expectations_this_quarter\" title=\"What are the main Anlon Healthcare Q2 results expectations this quarter?\">What are the main Anlon Healthcare Q2 results expectations this quarter?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#What_is_Anlon_Healthcare_share_price_today_ahead_of_the_Q2_earnings\" title=\"What is Anlon Healthcare share price today ahead of the Q2 earnings?\">What is Anlon Healthcare share price today ahead of the Q2 earnings?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-q2-results-fy27-preview-date-expectations\/#Is_Anlon_Healthcare_a_good_stock_to_buy_before_the_Q2_results\" title=\"Is Anlon Healthcare a good stock to buy before the Q2 results?\">Is Anlon Healthcare a good stock to buy before the Q2 results?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"When_Is_the_Anlon_Healthcare_Q2_Results_FY27_Date\"><\/span><strong>When Is the Anlon Healthcare Q2 Results FY27 Date?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Anlon Healthcare Q2 results date for FY27 is not confirmed. As of 9 September 2026, Anlon Healthcare Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.<\/p>\n<p>What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Anlon Healthcare Q2 results date becomes public through that filing rather than through any advance announcement.<\/p>\n<p>The Anlon Healthcare Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Anlon Healthcare.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Anlon_Healthcare_Q2_Results_Expectations_What_the_Market_Is_Actually_Tracking\"><\/span><strong>Anlon Healthcare Q2 Results Expectations: What the Market Is Actually Tracking<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No verified analyst estimate for the Anlon Healthcare Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Anlon Healthcare. The Anlon Healthcare Q2 results watchlist below is built from what the company has actually reported and disclosed.<\/p>\n<p>The first is the alternating pattern. Anlon Healthcare&#8217;s revenue has swung between roughly Rs 31 crore and Rs 55 crore in alternate quarters, with September 2025 and March 2026 both strong and June quarters weak, so the September base of Rs 52.20 crore is a demanding one.<\/p>\n<p>The second is margin, which has held in a reasonably narrow band. Operating margin was 24.08% in Q1 FY27 against 26.32% in the September 2025 quarter, so the profit gap between those two periods came mostly from volume.<\/p>\n<p>The third is order timing in excipients and speciality chemicals. Supply to formulation customers arrives in campaigns rather than evenly, which is the most likely explanation for the alternating revenue shape.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Anlon Healthcare Ltd. Live Fundamentals on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Anlon_Healthcare_Q2_Results_Preview_The_Q1_FY27_Actuals_It_Builds_On\"><\/span><strong>Anlon Healthcare Q2 Results Preview: The Q1 FY27 Actuals It Builds On<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Anlon Healthcare Ltd. reported revenue of Rs 30.98 crore in Q1 FY27, down 6.97% from Rs 33.30 crore in Q1 FY26, and a profit of Rs 4.80 crore at the net level, up 35.21% from Rs 3.55 crore in Q1 FY26. These are reported actuals, not estimates.<\/p>\n<p>Sequentially, revenue was down 44.10% over the March 2026 quarter figure of Rs 55.42 crore, and net profit was down 50.97% from Rs 9.79 crore in Q4 FY26. Operating margin stood at 24.08% in Q1 FY27 against 26.32% in the September 2025 quarter, which is the comparison the Anlon Healthcare Q2 results print will be read against.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Q2_FY26_Base_The_Comparison_Anlon_Healthcare_Q2_Results_FY27_Must_Beat\"><\/span><strong>Q2 FY26 Base: The Comparison Anlon Healthcare Q2 Results FY27 Must Beat<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Anlon Healthcare Ltd. reported revenue of Rs 52.20 crore and a profit of Rs 9.32 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Anlon Healthcare Q2 results preview.<\/p>\n<p>Net profit in that base quarter was above the Rs 4.80 crore just reported for Q1 FY27, so the year-on-year comparison starts from a demanding level. Revenue of Rs 52.20 crore sits above the Rs 30.98 crore of the June 2026 quarter, which frames how much sequential movement the Anlon Healthcare Q2 results print needs to show growth.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Anlon_Healthcare_Quarterly_Results_Trend_Over_the_Last_Four_Quarters\"><\/span><strong>Anlon Healthcare Quarterly Results Trend Over the Last Four Quarters<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Quarter<\/th>\n<th>Revenue (Rs Cr)<\/th>\n<th>Net Profit (Rs Cr)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Q2 FY26 (Sep 2025)<\/td>\n<td>52.20<\/td>\n<td>9.32<\/td>\n<\/tr>\n<tr>\n<td>Q3 FY26 (Dec 2025)<\/td>\n<td>35.58<\/td>\n<td>5.15<\/td>\n<\/tr>\n<tr>\n<td>Q4 FY26 (Mar 2026)<\/td>\n<td>55.42<\/td>\n<td>9.79<\/td>\n<\/tr>\n<tr>\n<td>Q1 FY27 (Jun 2026)<\/td>\n<td>30.98<\/td>\n<td>4.80<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company&#8217;s exchange filings, and they are the only basis this Anlon Healthcare Q2 results preview uses.<\/p>\n<p>Revenue across those four quarters ranged from Rs 30.98 crore to Rs 55.42 crore, and net profit from Rs 4.80 crore to Rs 9.79 crore. That spread is the honest context for the Anlon Healthcare Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Factors_That_Could_Shape_Anlon_Healthcare_Q2_Results_FY27\"><\/span><strong>Key Factors That Could Shape Anlon Healthcare Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Anlon Healthcare Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Anlon Healthcare has already reported.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Campaign-Based_Order_Flow\"><\/span><strong>Campaign-Based Order Flow<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Revenue of Rs 30.98 crore in June 2026 against Rs 55.42 crore in March 2026 is a swing of nearly half. Comparing consecutive quarters is therefore misleading, and only the year-on-year comparison against the same quarter is informative.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Customer_Concentration_and_Approvals\"><\/span><strong>Customer Concentration and Approvals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Excipient and active ingredient supply depends on being qualified into a customer&#8217;s formulation. Winning or losing a qualification changes revenue for several quarters, and it is disclosed in commentary rather than in the numbers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Recent_Listing_and_a_Strong_Run\"><\/span><strong>Recent Listing and a Strong Run<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The stock trades at Rs 16.05, close to its 52-week high of Rs 17.28 and well above its 52-week low of Rs 9.26, with a 14-day RSI of 71.91. Its listing history is short, so the moving averages cover a limited period.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Anlon_Healthcare_Q2_Results_FY27_Share_Price_and_Valuation_Going_Into_the_Print\"><\/span><strong>Anlon Healthcare Q2 Results FY27: Share Price and Valuation Going Into the Print<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Anlon Healthcare share price today is Rs 16.05 on the NSE, up Rs 0.44 or 2.82% from the previous close of Rs 15.61 on 9 September 2026, ahead of the Anlon Healthcare Q2 results announcement.<\/p>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Value (8 September 2026)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>NSE Symbol<\/td>\n<td>AHCL<\/td>\n<\/tr>\n<tr>\n<td>Current Market Price<\/td>\n<td>Rs 16.05<\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 17.28<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 9.26<\/td>\n<\/tr>\n<tr>\n<td>Market Capitalisation<\/td>\n<td>Rs 827 crore<\/td>\n<\/tr>\n<tr>\n<td>PE Ratio<\/td>\n<td>24.30<\/td>\n<\/tr>\n<tr>\n<td>Sector PE<\/td>\n<td>37.99<\/td>\n<\/tr>\n<tr>\n<td>PB Ratio<\/td>\n<td>3.59<\/td>\n<\/tr>\n<tr>\n<td>EPS (TTM)<\/td>\n<td>Rs 0.64<\/td>\n<\/tr>\n<tr>\n<td>Book Value per Share<\/td>\n<td>Rs 3.95<\/td>\n<\/tr>\n<tr>\n<td>Debt to Equity<\/td>\n<td>0.19<\/td>\n<\/tr>\n<tr>\n<td>Return on Equity<\/td>\n<td>19.20%<\/td>\n<\/tr>\n<tr>\n<td>50-Day Moving Average<\/td>\n<td>Rs 15.11<\/td>\n<\/tr>\n<tr>\n<td>200-Day Moving Average<\/td>\n<td>Rs 13.96<\/td>\n<\/tr>\n<tr>\n<td>RSI (14)<\/td>\n<td>71.91<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The stock trades above both its 50-day average of Rs 15.11 and its 200-day average of Rs 13.96, with a 14-day RSI of 71.91. None of this is a view on where the shares go once the Anlon Healthcare Q2 results are announced, and no price target is offered here.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Anlon Healthcare Ltd. live price and quarterly earnings updates.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Investors_Should_Watch_When_Anlon_Healthcare_Q2_Results_Are_Announced\"><\/span><strong>What Investors Should Watch When Anlon Healthcare Q2 Results Are Announced<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Four lines carry most of the information in a company of this size, and reading them in order keeps the Anlon Healthcare Q2 results print in proportion.<\/p>\n<ol>\n<li>Revenue against the Rs 52.20 crore reported in the September 2025 base quarter<\/li>\n<li>Net profit against a profit of Rs 9.32 crore in that same quarter<\/li>\n<li>Operating margin against 24.08% in Q1 FY27<\/li>\n<li>Any exceptional item, provision or one-off gain disclosed alongside the numbers<\/li>\n<\/ol>\n<p>A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Anlon Healthcare Q2 results announcement should be read together with the notes to the results rather than the headline alone.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_on_Anlon_Healthcare_Q2_Results_FY27\"><\/span><strong>Conclusion on Anlon Healthcare Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Anlon Healthcare Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Anlon Healthcare Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.<\/p>\n<p>On that basis the Anlon Healthcare Q2 results FY27 print faces a base of Rs 52.20 crore in revenue and a profit of Rs 9.32 crore, with the most recent quarter having delivered Rs 30.98 crore and a profit of Rs 4.80 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Anlon Healthcare, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Anlon_Healthcare_Q2_Results_FY27\"><\/span><strong>FAQs on Anlon Healthcare Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Anlon_Healthcare_Q2_results_date_for_FY27\"><\/span><strong>What is the Anlon Healthcare Q2 results date for FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Anlon Healthcare Q2 results date for FY27 is not confirmed. Anlon Healthcare Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_quarter_do_the_Anlon_Healthcare_Q2_results_2026_cover\"><\/span><strong>What quarter do the Anlon Healthcare Q2 results 2026 cover?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Anlon Healthcare Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Anlon Healthcare Ltd. reports revenue, operating profit and net profit for that period, and the Anlon Healthcare Q2 results filing also carries the notes to the accounts.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_the_Anlon_Healthcare_Q1_FY27_results\"><\/span><strong>What were the Anlon Healthcare Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Anlon Healthcare Ltd. reported revenue of Rs 30.98 crore in Q1 FY27 and a profit of Rs 4.80 crore at the net level. Revenue was down 6.97% versus Q1 FY26 and net profit was up 35.21% from Rs 3.55 crore in Q1 FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_Anlon_Healthcare_Q2_FY26_results_in_the_September_2025_quarter\"><\/span><strong>What were Anlon Healthcare Q2 FY26 results in the September 2025 quarter?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Anlon Healthcare Ltd. reported revenue of Rs 52.20 crore and a profit of Rs 9.32 crore in Q2 FY26. Operating margin was 26.32%. Those figures form the base for the Anlon Healthcare Q2 results FY27 comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_Anlon_Healthcare_Q2_results_expectations_this_quarter\"><\/span><strong>What are the main Anlon Healthcare Q2 results expectations this quarter?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No verified analyst estimate is publicly available. The Anlon Healthcare Q2 results expectations centre on revenue against the Rs 52.20 crore base, net profit against a profit of Rs 9.32 crore, operating margin against 24.08% in Q1 FY27, and any exceptional item disclosed with the numbers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Anlon_Healthcare_share_price_today_ahead_of_the_Q2_earnings\"><\/span><strong>What is Anlon Healthcare share price today ahead of the Q2 earnings?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Anlon Healthcare share price is Rs 16.05 on the NSE as of 9 September 2026, up 2.82% from Rs 15.61. The stock is about 7.1% below its 52-week high of Rs 17.28 and 73.3% above its 52-week low of Rs 9.26, at a market capitalisation of Rs 827 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Anlon_Healthcare_a_good_stock_to_buy_before_the_Q2_results\"><\/span><strong>Is Anlon Healthcare a good stock to buy before the Q2 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This article does not offer a buy, sell or hold recommendation on Anlon Healthcare Ltd.. The stock trades at a price-to-book ratio of 3.59 with a return on equity of 19.20%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Anlon Healthcare Q2 results date for FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Anlon Healthcare Q2 results date for FY27 is not confirmed. Anlon Healthcare Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.\"}},{\"@type\":\"Question\",\"name\":\"What quarter do the Anlon Healthcare Q2 results 2026 cover?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Anlon Healthcare Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Anlon Healthcare Ltd. reports revenue, operating profit and net profit for that period, and the Anlon Healthcare Q2 results filing also carries the notes to the accounts.\"}},{\"@type\":\"Question\",\"name\":\"What were the Anlon Healthcare Q1 FY27 results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Anlon Healthcare Ltd. reported revenue of Rs 30.98 crore in Q1 FY27 and a profit of Rs 4.80 crore at the net level. Revenue was down 6.97% versus Q1 FY26 and net profit was up 35.21% from Rs 3.55 crore in Q1 FY26.\"}},{\"@type\":\"Question\",\"name\":\"What were Anlon Healthcare Q2 FY26 results in the September 2025 quarter?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Anlon Healthcare Ltd. reported revenue of Rs 52.20 crore and a profit of Rs 9.32 crore in Q2 FY26. Operating margin was 26.32%. Those figures form the base for the Anlon Healthcare Q2 results FY27 comparison.\"}},{\"@type\":\"Question\",\"name\":\"What are the main Anlon Healthcare Q2 results expectations this quarter?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No verified analyst estimate is publicly available. The Anlon Healthcare Q2 results expectations centre on revenue against the Rs 52.20 crore base, net profit against a profit of Rs 9.32 crore, operating margin against 24.08% in Q1 FY27, and any exceptional item disclosed with the numbers.\"}},{\"@type\":\"Question\",\"name\":\"What is Anlon Healthcare share price today ahead of the Q2 earnings?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Anlon Healthcare share price is Rs 16.05 on the NSE as of 9 September 2026, up 2.82% from Rs 15.61. The stock is about 7.1% below its 52-week high of Rs 17.28 and 73.3% above its 52-week low of Rs 9.26, at a market capitalisation of Rs 827 crore.\"}},{\"@type\":\"Question\",\"name\":\"Is Anlon Healthcare a good stock to buy before the Q2 results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This article does not offer a buy, sell or hold recommendation on Anlon Healthcare Ltd.. The stock trades at a price-to-book ratio of 3.59 with a return on equity of 19.20%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Anlon Healthcare Q2 results FY27 date is not yet confirmed by the exchanges. Here is the September 2026 quarter watchlist for Anlon Healthcare Ltd., built on actual Q1 FY27 and Q2 FY26 numbers with no invented estimates.<\/p>\n","protected":false},"author":29,"featured_media":236110,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-236111","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["236110"],"rank_math_title":["Anlon Healthcare Q2 Results FY27: Date and Outlook"],"rank_math_description":["Anlon Healthcare Q2 results FY27 preview: results date status, key expectations, Q1 FY27 and Q2 FY26 actuals plus valuation before the September 2026 print."],"rank_math_focus_keyword":["Anlon Healthcare Q2 results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/anlon-healthcare-q2-results-fy27-preview-date-expectations.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/236111","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=236111"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/236111\/revisions"}],"predecessor-version":[{"id":236112,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/236111\/revisions\/236112"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/236110"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=236111"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=236111"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=236111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}